We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Ischemic Preconditioning Before CABG Surgery Improves Outcomes

By HospiMedica staff writers
Posted on 04 Sep 2007
A new study suggests that coronary artery bypass graft (CABG) surgery outcome may be improved if the blood supply to a patient's arm is restricted temporarily. More...


Researchers at University College London (UCL; UK) conducted a single-blinded randomized controlled study of 57 patients who underwent elective CABG surgery. Twenty-seven of them received remote ischemic preconditioning--three- to five-minute cycles of having the blood flow in one arm restricted using an automated cuff-inflator, with five-minute period between each cycle when the cuff was deflated. They were compared to a control group of 30 patients. All 57 had amounts of troponin T in their blood measured prior to surgery, and then six, 12, 24, 48, and 72 hours after surgery.

The researchers found that after 72 hours total troponin T released by the control group was 36.12 µg/l, compared to 20.58 µg/l in the remote ischemic preconditioning group, signifying a reduction of 43% in troponin T levels. The study was published in the August 18, 2007, issue of The Lancet.

"Our study has shown that remote ischemic preconditioning, mediated by transient upper limb ischemia, can reduce troponin T in the perioperative period in adult patients undergoing elective coronary artery bypass graft surgery,” said lead author professor of cellular cardiology Derek Yellon Ph.D., D.Sc., and colleagues. "One might expect that in high-risk patients for whom serum troponin T concentrations are substantially greater, remote ischemic preconditioning might confer an even greater reduction in myocardial injury.”

When there is damage to the heart during surgery, troponin T, a cardiac protein, can be released into the bloodstream. Short- and long-term outcomes following surgery are closely linked to release levels of such proteins.


Related Links:
University College London

Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Half Apron
Demi
ow Frequency Pulse Massager
ET10 L
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The fiber in the brain implant is less than half a millimeter thick (Photo courtesy of Peter Aagaard Brixen)

Brain Implant Records Neural Signals and Delivers Precise Medication

Neurological diseases such as epilepsy involve complex interactions across multiple layers of the brain, yet current implants can typically stimulate or record activity from only a single point.... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.